Angus Walker Appointed Alternate Director to Edward Myer

Sep 13, 2026 at 6:25 PM EDT · Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · Sep 13, 2026 at 6:25 PM EDT

On 6ix: 6ix.com/news/angus-walker-appointed-alternate-director-to-edward-myer

Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 BLS Pharmaceuticals Ltd | ASX:BLS | www.blspharma.com 1 14 September 2026 ANGUS WALKER APPOINTED AS ALTERNATE DIRECTOR TO EDWARD MYER BLS Pharmaceuticals Limited (ASX: BLS)...

View Attachment

6ix hasn’t read this filing yet.

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Application for quotation of securities - BLSSep 10
S&P DJI Announces September 2026 Quarterly RebalanceSep 4
Appendix 4G Corporate Governance StatementAug 31
BLS FY2027 GuidanceAug 30
BLS Investor PresentationAug 30

Later from BLS Pharmaceuticals

Initial Director's Interest NoticeSep 14
AGM Date and Director NominationsOct 6
Becoming a substantial holderOct 8
Ceasing to be a substantial holderOct 12
Quarterly Activities/Appendix 4C Cash Flow ReportOct 14

All BLS Pharmaceuticals news releases

Follow BLS Pharmaceuticals into a list and get an email when it puts out news.

Follow BLS Pharmaceuticals